Vermillion Presents Results Supporting Clinical Utility of Vasclir PAD Test | GenomeWeb

Vermillion last week reported results demonstrating the utility of its Vasclir protein biomarker test for peripheral artery disease.

In a poster at the Society for Vascular Medicine's annual meeting in Minneapolis, researchers led by Stanford professor of medicine John Cooke presented results from a 1,025-subject, multi-center prospective study that found the Vasclir test was able to identify 85 percent of PAD patients missed by the Framingham Risk Score – a conventional measure of risk for cardiovascular disease.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.

This week in Nature: Researchers describe the adaptation of organisms to environmental changes, while another study provides new insights into pig domestication.

The blog Sartorial Science seeks to challenge the stereotype of scientists as frumpy, messy, clueless dressers.

While one researcher says cloning the mammoth may be decades away, if successful, it may lead to a theme park of species that would no longer be extinct.

DNA Sequencing is being used by researchers in California to survey fish and marine life as part of a conservation effort.